German Company CureVac is Rushing to Make a COVID-19 Vaccine | NowThis
Tesla to create molecular printers for German developer of COVID-19 CureVac vaccine
On Wednesday, Tesla Inc CEO Elon Musk tweeted that he is working on mobile molecular printers to help create a potential COVID-19 vaccine being developed by CureVac in Germany..
German company CureVac says it is developing portable automated mRNA production devices, which it calls printers, and which Elon Musk named «RNA micro-factories».
They are being developed to be sent to remote locations where it will be possible to produce their vaccine and other mRNA-based therapies, depending on the recipe injected into the machine..
But for immediate use in the event of a pandemic – if the candidate vaccine gets market approval – CureVac has regulatory-approved manufacturing sites in Germany capable of producing hundreds of millions of doses..
A company based in Tübingen and supported by a foundation Bill and Melinda Gates, is a pioneer of the so-called messenger RNA approach, which is also used by BioNTech and its partner Pfizer, as well as Moderna.
RNA molecules are single-stranded versions of the DNA double helix. Due to their repeating molecular structure, they can be produced in a relatively simple biochemical process that does not require genetically modified living cells, which are necessary for the production of most other biotechnological drugs..
Coronavirus vaccine: Breaking down CureVac and mRNA technology
CureVac is also building a new permanent site that will help increase its production tenfold to billions of doses..
«Micro factories» will be built on the basis Tesla Grohmann Automation in Germany, Musk tweeted late Wednesday.
Tesla acquired a company that develops automated manufacturing systems for batteries and fuel cells in 2016 to expand its production.
CureVac is working with Tesla Grohmann to develop mobile printer technology, a source familiar with CureVac told Reuters..
Musk said in March that Tesla has additional FDA-approved ventilators that can be shipped free of charge to hospitals in regions where EVs are supplied..